Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001228749 | SCV001401165 | likely pathogenic | Ataxia-telangiectasia syndrome | 2019-11-12 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant has not been reported in the literature in individuals with ATM-related conditions. This variant results in the deletion of part of exon 13 (c.1899-8_1904del) of the ATM gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. |